Biotech firm ProfoundBio lands $112m Series B

Ally Bridge Group led the round.

13 February 2024•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals & Exits Briefs